Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

E 52862

Next Previous
X
Search
Drug Profile

E 52862

Alternative Names: E-52862; E-52862.HCl; MR-309; S1A; S1RA

Latest Information Update: 21 Mar 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Esteve
  • Developer ESTEVE
  • Class Non-opioid analgesics
  • Mechanism of Action Sigma-1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II COVID 2019 infections; Diabetic neuropathies; Neuropathic pain; Postherpetic neuralgia; Postoperative pain
  • No development reported Osteoarthritis

Most Recent Events

  • 14 Jan 2022 Phase-II clinical trials in COVID-2019 infections (In adults, In the elderly) in Spain (PO) (EudraCT2020-003603-33)
  • 28 Oct 2020 No recent reports of development identified for preclinical development in Osteoarthritis in Spain (PO)
  • 28 Nov 2016 Efficacy and adverse event data from a phase II trial in Post-operative pain presented at the 16th World Congress on Pain (WCP-2016)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top